AAPG ASCENTAGE PHARMA GROUP INTL
FollowSPONSORED ADS (ADR), issuer CIK 2023311
7 managers (7 13F filers) reported a position in AAPG shares at 2025-03-31, 237,194 shares in all. 7 filers opened a position and 0 filers sold out during the quarter.
- Managers
- 7
- 13F filers
- 7
- New
- 7
- Added
- 0
- Reduced
- 0
- Sold out
- 0
- Shares held by filers
- 237,194
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q1 2025
Filers in the available 13F reports with a share position at 2025-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Monashee Investment Management LLC | 159,942 | $3.51M | 0.42% | new | 13F-HRTimeline |
| Point72 (DIFC) Ltd | 25,404 | $558K | 0.05% | new | 13F-HRTimeline |
| XY Capital Ltd | 23,505 | $516K | 0.34% | new | 13F-HRTimeline |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 15,943 | $350K | <0.01% | new | 13F-HRTimeline |
| Verition Fund Management LLC | 9,922 | $218K | <0.01% | new | 13F-HRTimeline |
| UBS Group AGin group UBS Group AG | 2,478 | $54.4K | <0.01% | new | 13F-HRTimelineGroup |
| CONCOURSE FINANCIAL GROUP SECURITIES, I… | 0 | $0 | new | 13F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios. |